We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current PRVCF market cap is 9.86M. The company's latest EPS is CAD -0.0024 and P/E is -8.33.
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Revenue | 68k | 23k | 0 | 0 | 0 |
| Operating Income | -2.89M | -1.82M | -505k | -697k | -962k |
| Net Income | -3.58M | -3.8M | -1.73M | -1.48M | -1.27M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Assets | 857k | 302k | 161k | 189k | 181k |
| Total Liabilities | 5.34M | 3.91M | 4.27M | 4.82M | 5.96M |
| Total Equity | -4.49M | -3.6M | -4.1M | -4.64M | -5.78M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Operating | -994k | 64k | -426k | -223k | -297k |
| Investing | -1,000 | -2k | -52k | 1,000 | N/A |
| Financing | 867k | 183k | 137k | 212k | 294k |
| Market Cap | 9.86M |
| Price to Earnings Ratio | -8.33 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | -1.88 |
| Dividend Yield | - |
| Shares Outstanding | 541.7M |
| Average Volume (1 week) | 24.05k |
| Average Volume (1 Month) | 76.26k |
| 52 Week Change | 20.53% |
| 52 Week High | 0.0262 |
| 52 Week Low | 0.01 |
| Spread (Intraday) | 0.01 (37.32%) |
| Company Name | PreveCeutical Medical Inc (QB) |
| Address |
595 howe street 10th floor vancouver, british columbia V6C 2T5 |
| Website | https://www.preveceutical.com |
| Industry | miscellaneous metal ores,nec (1099) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
